Troluce Capital Advisors LLC Globus Medical Inc Transaction History
Troluce Capital Advisors LLC
- $1.35 Billion
- Q3 2024
A detailed history of Troluce Capital Advisors LLC transactions in Globus Medical Inc stock. As of the latest transaction made, Troluce Capital Advisors LLC holds 82,400 shares of GMED stock, worth $6.75 Million. This represents 2.06% of its overall portfolio holdings.
Number of Shares
82,400Holding current value
$6.75 Million% of portfolio
2.06%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding GMED
# of Institutions
479Shares Held
104MCall Options Held
183KPut Options Held
57.3K-
Vanguard Group Inc Valley Forge, PA10.6MShares$870 Million0.01% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$847 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X07MShares$573 Million0.27% of portfolio
-
State Street Corp Boston, MA3.57MShares$293 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.6MShares$213 Million0.02% of portfolio
About GLOBUS MEDICAL INC
- Ticker GMED
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 77,037,200
- Market Cap $6.31B
- Description
- Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...